Literature DB >> 15061673

Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanercept.

Kyongwook Yim1, Syed H Nazeer, Deanna Kiska, Frederick B Rose, Douglas Brown, Michael H Cynamon.   

Abstract

A case of recurrent Mycobacterium xenopi infection presenting as Pott's disease in a patient receiving etanercept for severe rheumatoid arthritis is described. A 49-y-old Caucasian male had received a total of 11 months of anti-mycobacterial therapy for hip infection acquired 15 months earlier; he presented with progressive back pain, which was diagnosed as Pott's disease. He had been treated with etanercept in addition to his prior immunosuppressive agents after the diagnosis of hip infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061673     DOI: 10.1080/00365540310017474

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

Review 1.  Prosthetic joint infection due to Mycobacterium xenopi: a review of the literature with a new case report.

Authors:  Paola Rodari; Stefania Marocco; Dora Buonfrate; Anna Beltrame; Chiara Piubelli; Pierantonio Orza; Veronica Andrea Fittipaldo; Zeno Bisoffi
Journal:  Infection       Date:  2019-05-16       Impact factor: 3.553

Review 2.  Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Rheumatol       Date:  2011-12-15       Impact factor: 2.980

3.  Prosthetic joint infection of the hip and knee due to Mycobacterium species: A systematic review.

Authors:  Asep Santoso; Krisna Yuarno Phatama; Sholahuddin Rhatomy; Nicolaas Cyrillus Budhiparama
Journal:  World J Orthop       Date:  2022-05-18

4.  Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.

Authors:  Shunsuke Mori; Hitoshi Tokuda; Fumikazu Sakai; Takeshi Johkoh; Akio Mimori; Norihiro Nishimoto; Sadatomo Tasaka; Kazuhiro Hatta; Hidekazu Matsushima; Shunji Kaise; Atsushi Kaneko; Shigeki Makino; Seiji Minota; Takashi Yamada; Shinobu Akagawa; Atsuyuki Kurashima
Journal:  Mod Rheumatol       Date:  2011-12-30       Impact factor: 3.023

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.